Fosun Pharma is likely to divest 5% equity in Gland Pharma via a block deal, according to reports. Fosun Pharma Industrial, the promoter of the company, holds 8,53,93,894 shares or 51.77% stake in the pharmaceutical company as of the quarter ended June 30, 2026, as per BSE data.
According to reports, a block deal has been launched in Gland Pharma through which Fosun Pharma will offload its stake. The floor price for the block deal is set at Rs 2,763 per share, which is at a discount of up to 5% to the current market price.